Results 11 to 20 of about 13,861,407 (312)

Hepatitis B Vaccines [PDF]

open access: yesThe Journal of Infectious Diseases, 2021
Abstract Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn, Jade   +3 more
openaire   +4 more sources

Global reporting of progress towards elimination of hepatitis B and hepatitis C.

open access: yesThe Lancet Gastroenterology and Hepatology, 2023
BACKGROUND The 69th World Health Assembly endorsed the global health sector strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030.
F. Cui   +20 more
semanticscholar   +1 more source

Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

open access: yesThe Lancet Gastroenterology and Hepatology, 2022
BACKGROUND Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) and Interim Guidance for Country ...

semanticscholar   +1 more source

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023

open access: yesMMWR Recommendations and Reports, 2023
Summary Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative, antiviral treatment, monitoring, and liver cancer surveillance can reduce morbidity and mortality. Effective
E. Conners   +15 more
semanticscholar   +1 more source

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment

open access: yesJournal of Patient-Reported Outcomes, 2021
Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland   +6 more
doaj   +1 more source

Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study

open access: yesBMC Public Health, 2021
Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland   +8 more
doaj   +1 more source

Alinity m, a Random-Access System, for Hepatitis B Virus DNA Quantification in Plasma and Whole Blood Collected on Dried Blood Spots

open access: yesmSphere, 2022
The International Liver Association recommends the use of accurate and sensitive molecular methods for determination of hepatitis B virus (HBV) DNA levels in plasma or serum of chronic HBsAg carriers. The level of HBV replication represents the strongest
Valérie Ortonne   +7 more
doaj   +1 more source

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

open access: yesHepatology International, 2021
Hepatitis B reactivation related to the use of immunosuppressive therapy remains a major cause of liver-related morbidity and mortality in hepatitis B endemic Asia-Pacific region.
G. Lau   +29 more
semanticscholar   +1 more source

The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives

open access: yesInternational Journal for Equity in Health, 2022
Background An estimated 296 million individuals live with chronic hepatitis B worldwide, most have not been diagnosed and remain at risk of liver disease and cancer.
Catherine Freeland   +4 more
doaj   +1 more source

Hepatitis B

open access: yesThe Lancet, 2023
Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis B core antibody (IgM anti-HBc, for the window period when ...
Jeng, W.-J.   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy